Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2332827
Max Phase: Preclinical
Molecular Formula: C31H37N9O7
Molecular Weight: 647.69
Molecule Type: Protein
Associated Items:
ID: ALA2332827
Max Phase: Preclinical
Molecular Formula: C31H37N9O7
Molecular Weight: 647.69
Molecule Type: Protein
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CNC(=O)C[C@@H](C(=O)O)NC(=O)[C@@H](c2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O
Standard InChI: InChI=1S/C31H37N9O7/c32-31(33)34-12-6-11-21-27(43)38-22(13-18-15-35-20-10-5-4-9-19(18)20)28(44)40-26(17-7-2-1-3-8-17)29(45)39-23(30(46)47)14-24(41)36-16-25(42)37-21/h1-5,7-10,15,21-23,26,35H,6,11-14,16H2,(H,36,41)(H,37,42)(H,38,43)(H,39,45)(H,40,44)(H,46,47)(H4,32,33,34)/t21-,22+,23-,26+/m0/s1
Standard InChI Key: UXIFXRPPOKZVPG-DUOVIKOCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 647.69 | Molecular Weight (Monoisotopic): 647.2816 | AlogP: -1.11 | #Rotatable Bonds: 8 |
Polar Surface Area: 260.49 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.60 | CX Basic pKa: 11.92 | CX LogP: -3.33 | CX LogD: -3.33 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.08 | Np Likeness Score: 0.74 |
1. Bochen A, Marelli UK, Otto E, Pallarola D, Mas-Moruno C, Di Leva FS, Boehm H, Spatz JP, Novellino E, Kessler H, Marinelli L.. (2013) Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids., 56 (4): [PMID:23362923] [10.1021/jm301221x] |
Source(1):